• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 清除时间在非裔、白人和亚裔族群中的差异。

Time to SARS-CoV-2 clearance in African, Caucasian, and Asian ethnic groups.

机构信息

Service Laboratoire, Clinique Aries Medicus, Port-Gentil, Gabon.

Department of Public Health, Faculty of Health Sciences, Kesmonds International University, Bamenda, Cameroon.

出版信息

Influenza Other Respir Viruses. 2024 Jun;18(6):e13238. doi: 10.1111/irv.13238.

DOI:10.1111/irv.13238
PMID:38838076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11150056/
Abstract

BACKGROUND

COVID-19 may become a seasonal disease. SARS-CoV-2 active circulation coupled with vaccination efforts has undoubtedly modified the virus dynamic. It is therefore important investigate SARS-CoV-2 dynamic in different groups of population following the course of spatiotemporal variance and immunization.

METHODS

To investigate SARS-CoV-2 clearance in different ethnic groups and the impact of immunization, we recruited 777 SARS-CoV-2-positive patients (570 Africans, 156 Caucasians, and 51 Asians). Participants were followed and regularly tested for 2 months until they had two negative tests.

RESULTS

The vaccination rate was 64.6%. African individuals were less symptomatic (2%), Caucasians (41%) and Asians (36.6%). On average, viral clearance occurred after 10.5 days. Viral load at diagnosis was inversely correlated with viral clearance (p < 0.0001). The time of SARS-CoV-2 clearance was higher in Africans and Caucasians than in Asians (Dunn's test p < 0.0001 and p < 0.05, respectively). On average, viral clearance occurred within 9.5 days during the second semester (higher rate of vaccination and SARS-CoV-2 exposition), whereas it took 13.6 days during the first semester (lower rate of vaccination and SARS-CoV-2 exposition) (Mann-Whitney t-test p < 0.0001).

CONCLUSION

In conclusion, ethnicity and spatiotemporal changes including SARS-CoV-2 exposition and immunization affect SARS-CoV-2 clearance.

摘要

背景

COVID-19 可能成为一种季节性疾病。SARS-CoV-2 的活跃传播加上疫苗接种工作,无疑改变了病毒的动态。因此,重要的是要在时空变化和免疫接种的背景下,研究不同人群中 SARS-CoV-2 的动态。

方法

为了研究不同人群中 SARS-CoV-2 的清除情况以及免疫接种的影响,我们招募了 777 名 SARS-CoV-2 阳性患者(570 名非洲人、156 名白种人和 51 名亚洲人)。对参与者进行了随访,并定期进行检测,直到他们有两次阴性检测结果。

结果

疫苗接种率为 64.6%。非洲人症状较轻(2%),白种人(41%)和亚洲人(36.6%)。平均而言,病毒清除发生在 10.5 天后。诊断时的病毒载量与病毒清除呈负相关(p<0.0001)。非洲人和白种人的 SARS-CoV-2 清除时间高于亚洲人(Dunn 检验 p<0.0001 和 p<0.05)。平均而言,在第二学期内,病毒清除发生在 9.5 天内(接种率和 SARS-CoV-2 暴露率较高),而在第一学期内,病毒清除需要 13.6 天(接种率和 SARS-CoV-2 暴露率较低)(Mann-Whitney t 检验 p<0.0001)。

结论

总之,种族和时空变化,包括 SARS-CoV-2 暴露和免疫接种,影响 SARS-CoV-2 的清除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/cb7f53f5d654/IRV-18-e13238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/0665dcd5131f/IRV-18-e13238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/006422cf95a7/IRV-18-e13238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/d2a6fe07fd3a/IRV-18-e13238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/5f91eda8ada7/IRV-18-e13238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/cb7f53f5d654/IRV-18-e13238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/0665dcd5131f/IRV-18-e13238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/006422cf95a7/IRV-18-e13238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/d2a6fe07fd3a/IRV-18-e13238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/5f91eda8ada7/IRV-18-e13238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/11150056/cb7f53f5d654/IRV-18-e13238-g003.jpg

相似文献

1
Time to SARS-CoV-2 clearance in African, Caucasian, and Asian ethnic groups.SARS-CoV-2 清除时间在非裔、白人和亚裔族群中的差异。
Influenza Other Respir Viruses. 2024 Jun;18(6):e13238. doi: 10.1111/irv.13238.
2
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
3
Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom.美国和英国不同种族和族裔群体参与者的自我报告的 COVID-19 疫苗犹豫和接种情况。
Nat Commun. 2022 Feb 1;13(1):636. doi: 10.1038/s41467-022-28200-3.
4
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.2022 年至 2023 年秋冬期间,老年欧洲人群中的 COVID-19 疫苗有效性。
JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258.
5
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率:哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
6
SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.2022年5月至11月荷兰阿姆斯特丹六个种族群体中的新型冠状病毒感染和疫苗接种情况
Epidemiol Infect. 2025 Jan 23;153:e23. doi: 10.1017/S0950268825000056.
7
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.在 COVID 症状研究应用程序的英国用户中,疫苗接种后 SARS-CoV-2 感染的风险因素和疾病特征:一项前瞻性、基于社区的、嵌套的病例对照研究。
Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1.
8
Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.英国大曼彻斯特地区 COVID-19 疫苗接种率的种族差异及其与季节性流感疫苗接种率的比较:一项队列研究。
PLoS Med. 2022 Mar 3;19(3):e1003932. doi: 10.1371/journal.pmed.1003932. eCollection 2022 Mar.
9
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.一种雾化型腺病毒 5 型载体新冠疫苗(Ad5-nCoV)在成年人中的安全性、耐受性和免疫原性:一项开放标签、随机 1 期临床试验的初步报告。
Lancet Infect Dis. 2021 Dec;21(12):1654-1664. doi: 10.1016/S1473-3099(21)00396-0. Epub 2021 Jul 26.
10
Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study.英格兰 COVID-19 住院治疗中的族裔差异:基于社区队列研究的社会经济因素、心理健康以及炎症和促炎因素的作用。
Brain Behav Immun. 2020 Aug;88:44-49. doi: 10.1016/j.bbi.2020.05.074. Epub 2020 Jun 1.

引用本文的文献

1
Factors influencing the time to COVID-19 antigen tests negative conversion among students at a Chinese university: a retrospective analysis.影响中国某大学学生新冠病毒抗原检测转阴时间的因素:一项回顾性分析
BMC Infect Dis. 2024 Dec 18;24(1):1443. doi: 10.1186/s12879-024-10346-8.

本文引用的文献

1
Racial and ethnic variation in COVID-19 care, treatment, and outcomes: A retrospective cohort study from the MiCOVID-19 registry.COVID-19 护理、治疗和结局的种族和民族差异:来自 MiCOVID-19 注册的回顾性队列研究。
PLoS One. 2022 Nov 1;17(11):e0276806. doi: 10.1371/journal.pone.0276806. eCollection 2022.
2
Trend of expansion of SARS-CoV-2 infection and COVID-19 burden in Gabon (Central Africa) in mid-2021, based on a serological survey.基于血清学调查的2021年年中加蓬(中非)SARS-CoV-2感染扩展趋势及新冠疫情负担
IJID Reg. 2022 Dec;5:13-17. doi: 10.1016/j.ijregi.2022.08.006. Epub 2022 Aug 27.
3
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021.
非洲的 SARS-CoV-2 感染:2020 年 1 月至 2021 年 12 月标准化血清流行率研究的系统评价和荟萃分析。
BMJ Glob Health. 2022 Aug;7(8). doi: 10.1136/bmjgh-2022-008793.
4
Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies.表征 SARS-CoV-2 病毒清除动力学,以改进抗病毒药物代谢动力学研究设计。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0019222. doi: 10.1128/aac.00192-22. Epub 2022 Jun 23.
5
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.未接种疫苗和接种疫苗的个体中感染原始、Delta 或奥密克戎 SARS-CoV-2 的传染性病毒载量。
Nat Med. 2022 Jul;28(7):1491-1500. doi: 10.1038/s41591-022-01816-0. Epub 2022 Apr 8.
6
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.接种疫苗和未接种疫苗人群中新冠病毒变异株的病毒动力学
N Engl J Med. 2021 Dec 23;385(26):2489-2491. doi: 10.1056/NEJMc2102507. Epub 2021 Dec 1.
7
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.在 COVID 症状研究应用程序的英国用户中,疫苗接种后 SARS-CoV-2 感染的风险因素和疾病特征:一项前瞻性、基于社区的、嵌套的病例对照研究。
Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1.
8
SARS-CoV-2 emerging variants in Africa: view from Gabon.非洲的新冠病毒新兴变种:加蓬视角
Lancet Microbe. 2021 Aug;2(8):e349. doi: 10.1016/S2666-5247(21)00125-7. Epub 2021 Jun 8.
9
Continent-Wide Analysis of COVID 19: Total Cases, Deaths, Tests, Socio-Economic, and Morbidity Factors Associated to the Mortality Rate, and Forecasting Analysis in 2020-2021.全球范围内的 COVID-19 分析:与死亡率相关的总病例、死亡、检测、社会经济和发病率因素,以及 2020-2021 年的预测分析。
Int J Environ Res Public Health. 2021 May 18;18(10):5350. doi: 10.3390/ijerph18105350.
10
Dynamic and features of SARS-CoV-2 infection in Gabon.加蓬的 SARS-CoV-2 感染的动态和特征。
Sci Rep. 2021 May 6;11(1):9672. doi: 10.1038/s41598-021-87043-y.